Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab
Publication date: Available online 11 December 2017 Source:European Journal of Cancer Author(s): Max Rogatsch, Johannes Schmid, Sigurd Lax, Maximilian Uranitsch, Karin Schmid-Zalaudek, Roberta Giuffrida, Iris Zalaudek
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου